Vice President of People Operations, Precision Neuroscience
$160-190k
More information about location
Office located in Manhattan, NY
Building powerful, minimally invasive brain implants
Open for applications
Building powerful, minimally invasive brain implants
21-100 employees
Open for applications
$160-190k
More information about location
Office located in Manhattan, NY
21-100 employees
Company mission
To provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses.
Jump to section
Company mission
To provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses.
Our take
Precision Neuroscience is finding new, practical ways of improving the lives of those who are suffering from neurological conditions.
The Layer 7 Cortical Interface is an implant that’s 1/5th the thickness of a human hair and can be fitted onto the human brain without damaging it. Through minimally invasive micro-slit surgery, the brain implant can process data and aims to move brain-computer interfaces (BCI) technology from small-scale research into a new era of worldwide usage.
The long-term goal of the Layer 7 Cortical Interface is to allow customers to interact with people and the world via digital means. Whilst the market is blooming with new companies exploring the possibilities of BCI technology, Precision has an advantage in that its solution requires minimal surgery and is reversible, meaning that it has wider implications than just neurological disorders.
Work is ongoing but with substantial funding behind it, Precision is using its investment to ramp up product development and FDA regulatory review as well as expanding its team.
Freddie
Company Specialist at Welcome to the Jungle
Company values
- We believe that the best technology puts people first. While brain–computer interface technology has exciting implications for the future of computing, everything we do at Precision is geared towards creating tangible, near-term benefits for our users: people suffering from neurological disorders.
Funding (last 2 of 4 rounds)
Dec 2024
$102m
SERIES C
Nov 2024
$93m
LATE VC
Total funding: $249m
Leadership
Michael Mager
(CEO & Co-Founder)Currently Co-Chairman at Assembly Software and Partner at Ridge Road Partners, Board Member at Supply Finance.
Mark Hettick
(Vice President of Engineering - Microfabrication)Previously Process Engineer at Neuralink, Lead Safety Coordinator at Berkeley Labs and Research Assistant at the Joint Center for Artificial Photosynthesis.
Benjamin Rapoport
(Chief Science Officer & Co-Founder)Previously Scientific Director of the BioDesign Program at Mount Sinai Health Systems. Previously Neurosurgery Residency at Weill Cornell Medicine and Founding Member at Neuralink.
Office
Articles
Jobs (10)
Software Engineering
People, HR, Recruitment
Operations & Strategy
Design
Other Engineering